ABBV-383

• Target :

  Integrin

• Related Pathways :

  Cytoskeletal Signaling

• Bioactivity :

  ABBV-383 (ABBV-383), a BCMA x CD3 bispecific T-cell engager (BiTE), targets and inhibits the B-cell maturation antigen (BCMA) while concurrently activating the T-cell surface glycoprotein CD3 complex. This compound is utilized in research focused on multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C